Abstract
The stabilities of the inclusion compounds of three chemotherapeutic agents, camptothecin (CPT), docetaxel (DOC) and idarubicin (IDA), plus a model compound 1,4-dihydroxyanthraquinone (DHA) with several β-cyclodextrin (β-CD) derivatives were investigated by solubility measurements, isothermal titration microcalorimetry and fluorescence anisotropy measurements. Ionic heptakis-(6-deoxy-6-thioethers) of β-CD were found to exhibit very high binding potentials for these drugs making them to good candidates for advanced drug delivery.
Similar content being viewed by others
Abbreviations
- CD:
-
Cyclodextrin
- CPT:
-
Camptothecin
- DHA:
-
1, 4-Dihydroxyanthraquinone
- DOC:
-
Docetaxel
- HPβCD:
-
Hydroxypropyl-β-cylodextrin
- IDA:
-
Idarubicin
- ITC:
-
Isothermal titration calorimetry
References
Wenz, G.: Cyclodextrins as building blocks for supramolecular structures and functional units. Angew. Chem., Int. Ed. 33, 803–822 (1994)
Müller, A., Wenz, G.: Thickness recognition of bola-amphiphiles by α-cyclodextrin. Chem. Eur. J. 13, 2218–2223 (2007)
Szejtli, J.: Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98, 1743–1753 (1998)
Wenz, G.: An overview of host–guest chemistry and its application to nonsteroidal anti-inflammatory drugs. Clin. Drug Investig. 19(Suppl 2), 21–25 (2000)
Davis, M.E., Brewster, M.E.: Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug Discov. 3, 1023–1035 (2004)
Holland, L., Rizzi, G., Malton, P.: Cosmetic compositions containing cyclic oligosaccharides for long-lasting fragrances. Patent WO 2000067717. The Procter and Gamble Company. PCT Int. Appl., 2000
Desiderio, C., Fanali, S.: Use of negatively charged sulfobutyl ether-β-cyclodextrin for enantiomeric separation by capillary electrophoresis. J. Chromatogr. A. 716, 183–196 (1995)
Mikus, P., Kaniansky, D., Fanali, S.: Separation of multicomponent mixtures of 2,4-dinitrophenyl labelled amino acids and their enantiomers by capillary zone electrophoresis. Electrophoresis 22, 470–477 (2001)
Connors, K.A.: The stability of cyclodextrin complexes in solution. Chem. Rev. 97, 1325–1357 (1997)
Frijlink, H.W., Eissens, A.C., Hefting, N.R., Poelstra, K., Lerk, C.F., Meijer, D.K.F.: The effect of parenterally administered cyclodextrins on cholesterol level in the rat. Pharm. Res. 8, 9–16 (1991)
Irie, T., Uekama, K.: Pharmaceutical applications of cyclodextrins. 3. Toxicological issues and safety evaluation. J. Pharm. Sci. 86, 147–162 (1997)
Stella, V.J., Rajewski, R.A.: Cyclodextrins: their future in drug formulation and delivery. Pharm. Res. 14, 556–567 (1997)
Kitae, T., Nakayama, T., Kano, K.: Chiral recognition of α-amino acids by charged cyclodextrins through cooperative effects of coulomb interaction and inclusion. J. Chem. Soc., Perkin Trans. 2, 207–212 (1998)
Wenz, G., Strassnig, C., Thiele, C., Engelke, A., Morgenstern, B., Hegetschweiler, K.: Recognition of ionic guests by ionic b-cyclodextrin derivatives. Chem. Eur. J. 14, 7202–7211 (2008)
Lundberg, B.B.: Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions. Anti-Cancer Drug Des. 13, 453 (1998)
Kang, J., Kumar, V., Yang, D., Chowdhury, P.R., Hohl, R.J.: Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent. Eur. J. Pharm. Sci. 15, 163–170 (2002)
Steffen, A., Thiele, C., Tietze, S., Strassnig, C., Kämper, A., Lengauer, T., Wenz, G., Apostolakis, J.: Improved cyclodextrin based receptors for camptothecin by inverse virtual screening. Chem. Eur. J. 13, 6801–6809 (2007)
Lyseng-Williamson, K.A., Fenton, C.: Docetaxel—a review of its use in metastatic breast cancer. Drugs 65, 2513–2531 (2005)
Figitt, D.P., Wiseman, L.R.: Docetaxel—an update of its use in advanced breast cancer. Drugs 59, 621–651 (2000)
Defaye, J., Ortiz-Mellet, C., Fernandez, J.M.G., Maciejewski, S.: Thioureido-β-cyclodextrins as molecular carriers for the anticancer drug taxotere. In: Coleman, A.W. (ed.) Proceedings of the Ninth International Symposium on Molecular Recognition and Inclusion, pp. 313–316. Kluwer Acad. (1998)
Benito, J.M., Gómez-García, M., Mellet, C.O., Baussanne, I., Defaye, J., García Fernández, J.M.: Optimizing saccharide-directed molecular delivery to biological receptors: design, synthesis, and biological evaluation of glycodendrimer-cyclodextrin conjugates. J. Am. Chem. Soc. 126, 10355–10363 (2004)
Di Marino, A., Rubio, L., Mendicuti, F.: Fluorescence and molecular mechanics of 1-methyl naphthalenecarboxylate/cyclodextrin complexes in aqueous medium. J. Incl. Phenom. Macrocycl. Chem. 58, 103–114 (2007)
Hirose, K.: A practical guide for the determination of binding constants. J. Incl. Phenom. Macrocycl. Chem. 39, 193–209 (2001)
Chmurski, K., Defaye, J.: An improved synthesis of per(6-deoxyhalo)cyclodextrin using N-halosuccinimides-triphenylphosphine in DMF. Supramol. Chem. 12, 221–224 (2000)
Loftsson, T., Hreinsdottir, D., Masson, M.: Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302, 18–28 (2005)
Schneider, H.-J.: Binding mechanisms in supramolecular complexes. Angew. Chem., Int. Ed. 48, 3924–3977 (2009)
Acknowledgements
The authors thank R. Heisel and A. Engelke for technical assistance and the Federal Ministry of Education and Research of Germany (Project Number 13N9133) for financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thiele, C., Auerbach, D., Jung, G. et al. Inclusion of chemotherapeutic agents in substituted β-cyclodextrin derivatives. J Incl Phenom Macrocycl Chem 69, 303–307 (2011). https://doi.org/10.1007/s10847-010-9741-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-010-9741-4